| P50 | author | Shilo VIu | Q70241665 |
| P2093 | author name string | Joe G N Garcia | |
| | David E Schwartz | |
| | Sergei M Danilov | |
| | Olga A Kost | |
| | Alexandr V Tarasov | |
| | Maxim N Petrov | |
| P2860 | cites work | Crystal structure of the human angiotensin-converting enzyme-lisinopril complex | Q24293072 |
| | Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning | Q24293181 |
| | Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review | Q24816744 |
| | Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE | Q28116521 |
| | Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes | Q28117934 |
| | Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence | Q28320615 |
| | Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain | Q28473818 |
| | An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding | Q31037765 |
| | Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme | Q33290817 |
| | Epitope mapping of mAbs to denatured human testicular ACE (CD143). | Q33359863 |
| | Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis | Q34004393 |
| | Angiotensin-converting enzyme inhibitors | Q34236623 |
| | Antihypertensive agents in hemodialysis patients: a current perspective | Q34700870 |
| | The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia | Q34952514 |
| | Oxidant stress in hemodialysis patients: what are the determining factors? | Q35093664 |
| | Review on uremic toxins: classification, concentration, and interindividual variability | Q35098883 |
| | Secretase-mediated cell surface shedding of the angiotensin-converting enzyme | Q35950481 |
| | Six truisms concerning ACE and the renin-angiotensin system educed from the genetic analysis of mice | Q36157768 |
| | Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation | Q36271080 |
| | Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids | Q36457792 |
| | ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? | Q36719942 |
| | Assignment of free and disulfide-bonded cysteine residues in testis angiotensin-converting enzyme: functional implications | Q36813413 |
| | Spontaneous solubilization of membrane-bound human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells | Q37391532 |
| | Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis | Q37505732 |
| | Angiotensin-converting enzyme: new concepts concerning its biological role | Q38206789 |
| | Monoclonal Antibodies 1G12 and 6A12 to the N-domain of human angiotensin-converting enzyme: fine epitope mapping and antibody-based detection of ACE inhibitors in human blood | Q38304268 |
| | Conformational Fingerprinting of the Angiotensin I-Converting Enzyme (ACE). 1. Application in Sarcoidosis | Q39651180 |
| | Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis | Q39950095 |
| | Angiotensin-Converting Enzyme: Vascular Endothelial Localization | Q39976181 |
| | Elevation of Serum Angiotensin-Converting Enzyme in Gaucher's Disease | Q39991377 |
| | A Sensitive Fluorimetric Assay for Serum Angiotensin-con venrting Enzyme | Q40004952 |
| | Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: clinical and possible pathogenic significance | Q40012687 |
| | Angiotensin-converting enzyme in macrophages and Freund's adjuvant granuloma | Q40140445 |
| | Serum angiotensin converting enzyme activity in patients with chronic renal failure on long term hemodialysis | Q40223052 |
| | Mammalian inhibitors of angiotensin converting enzyme (kininase II) | Q40278426 |
| | Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies | Q40303273 |
| | Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery | Q40322222 |
| | Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface | Q41866586 |
| | Isolation of angiotensin-converting enzyme inhibitor from porcine plasma | Q42206066 |
| | Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface | Q42442665 |
| | Angiotensin-converting enzyme in epithelial and neuroepithelial cells | Q42453268 |
| | Fine epitope mapping of monoclonal antibodies 9B9 and 3G8 to the N domain of angiotensin-converting enzyme (CD143) defines a region involved in regulating angiotensin-converting enzyme dimerization and shedding | Q42464195 |
| | Isolation of two differentially glycosylated forms of peptidyl-dipeptidase A (angiotensin converting enzyme) from pig brain: a re-evaluation of their role in neuropeptide metabolism | Q42855338 |
| | Endogenous inhibitor of angiotensin converting enzyme in the rat heart | Q44136255 |
| | Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage | Q44569733 |
| | Interference of plasmatic reduced glutathione and hemolysis on glutathione disulfide levels in human blood. | Q45129254 |
| | Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments | Q45219667 |
| | Development and characterization of rat monoclonal antibodies to denatured mouse angiotensin-converting enzyme | Q45282309 |
| | Simultaneous determination of ACE activity with 2 substrates provides information on the status of somatic ACE and allows detection of inhibitors in human blood | Q46470426 |
| | Testicular isoform of angiotensin I-converting enzyme (ACE, CD143) on the surface of human spermatozoa: revelation and quantification using monoclonal antibodies | Q46858354 |
| | Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats | Q46883739 |
| | Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. | Q46907104 |
| | Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. | Q46942783 |
| | Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions | Q46972854 |
| | Observation of high and low molecular weight inhibitors of angiotensin-converting enzyme in rat lung | Q47331823 |
| | Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. | Q47334417 |
| | Clinical and biochemical aspects of sarcoidosis. With special reference to angiotensin-converting enzyme (ACE). | Q50583467 |
| | Mapping of conformational mAb epitopes to the C domain of human angiotensin I-converting enzyme. | Q51788222 |
| | Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action. | Q51808629 |
| | Localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies. | Q51818093 |
| | Monoclonal antibodies 1B3 and 5C8 as probes for monitoring the integrity of the C-terminal end of soluble angiotensin-converting enzyme. | Q51818510 |
| | An angiotensin-converting enzyme (ACE) inhibitor in human serum. Increased sensitivity of the serum ACE assay for detecting active sarcoidosis. | Q52620527 |
| | Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease | Q56775014 |
| | Heterogeneous distribution of angiotensin I-converting enzyme (CD143) in the human and rat vascular systems: vessel, organ and species specificity | Q57214332 |
| | Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? | Q64112079 |
| | Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme | Q64378851 |
| | Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters | Q67912185 |
| | Studies on the angiotensin converting enzyme with different substrates | Q68608796 |
| | Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization | Q70144265 |
| | Angiotensin-converting enzyme in cultured endothelial cells. Synthesis, degradation, and transfer to culture medium | Q70178494 |
| | Increased Serum Angiotensin-Converting Enzyme in Chronic Renal Disease | Q70220106 |
| | Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies | Q71503825 |
| | Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site | Q71650804 |
| | Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension | Q72408805 |
| | Monoclonal antibodies to denatured human ACE (CD 143), broad species specificity, reactivity on paraffin sections, and detection of subtle conformational changes in the C-terminal domain of ACE | Q73092337 |
| | Isolation of angiotensin converting enzyme (ACE) binding protein from human serum with an ACE affinity column | Q73118013 |
| | Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells | Q77157569 |
| | Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC | Q77164603 |
| | ACE inhibitors and survival of hemodialysis patients | Q78450239 |
| | Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease | Q78874568 |
| | Detection of mutated angiotensin I-converting enzyme by serum/plasma analysis using a pair of monoclonal antibodies | Q81782222 |
| | Porcine pulmonary angiotensin I-converting enzyme--biochemical characterization and spatial arrangement of the N- and C-domains by three-dimensional electron microscopic reconstruction | Q84125603 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e49290 | |
| P577 | publication date | 2012-11-16 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Conformational changes of blood ACE in chronic uremia | |
| P478 | volume | 7 | |